FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to formula 1 compounds, possessing properties of Xa factor inhibitors, their pharmaceutically acceptable salts and based on them pharmaceutical compositions. In formula 1 
cycle A stands for residue, selected from group, including the following structures: 
R1-R12 independently represents H, (C1-C7)alkyl or (C3-C7)cycloalkyl, R3 and R4 form cycle by binding (C3-C5)alkylene, alkylene carbon atom can be substituted with carbonyl; R13 stands for H, (C1-C7)alkyl or formyl.
EFFECT: obtaining compounds, possessing properties of Xa factor inhibitors.
8 cl, 5 ex, 3 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW OXAZOLIDINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT | 2012 |
|
RU2617408C2 |
| NOVEL OXAZOLIDINONE DERIVATIVES WITH CYCLIC AMIDOXIM OR CYCLIC AMIDRAZONE AND CONTAINING THEM PHARMACEUTICAL COMPOSITIONS | 2009 |
|
RU2468023C1 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| INDOLE AND INDAZOLE COMPOUNDS AS CELLULAR NECROSIS INHIBITORS | 2008 |
|
RU2437883C1 |
| INDOLE COMPOUNDS AS CELL NECROSIS INHIBITORS | 2008 |
|
RU2477282C2 |
| INDOLE AND INDAZOLE DERIVATIVES SHOWING PRESERVING ACTION ON CELLS, TISSUES AND ORGANS | 2009 |
|
RU2460525C2 |
| TRICYCLIC NITROGEN-CONTAINING DERIVATIVES OF IMIDAZO[4,5-C]PYRIDINE, HAVING INHIBITING ACTIVITY IN RESPONSE TO HYSTAMINE 4 RECEPTOR (HH4R) | 2012 |
|
RU2628074C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| BIARYL- OR HETEROCYCLIC BIARYL-SUBSTITUTED DERIVATIVES OF CYCLOHEXENE AS CETP INHIBITORS | 2014 |
|
RU2627361C2 |
| COMPOUNDS CONTAINING A CLEAVABLE LINKER AND METHODS FOR THEIR USE | 2018 |
|
RU2795168C2 |
